Wanhui Double-Crane Pharmaceutical: Exclusive Distributor Of LG Life Hypoglycemic Agents In China
This article was originally published in PharmAsia News
Executive Summary
Beijing Wanhui Double-Crane Pharmaceutical signed Jan. 12 an exclusive "license, supply and distribution agreement" with South Korea's LG Life Science to supply the type-2 diabetes LC-15-0444 drugs developed by LG Life in China